The cost‐effectiveness of the Dose Adjustment for Normal Eating (DAFNE) structured education programme: an update using the Sheffield Type 1 Diabetes Policy Model
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims: To estimate the cost‐effectiveness of training in flexible intensive insulin therapy [as provided in the Dose Adjustment for Normal Eating (DAFNE) structured education programme] compared with no training for adults with Type 1 diabetes mellitus in the UK using the Sheffield Type 1 Diabetes Policy Model. Methods: The Sheffield Type 1 Diabetes Policy Model was used to simulate the development of long‐term microvascular and macrovascular diabetes‐related complications and the occurrence of diabetes‐related adverse events in 5000 adults with Type 1 diabetes. Total costs and quality‐adjusted life years were estimated from a National Health Service perspective over a lifetime horizon, discounted at a rate of 3.5%. The treatment effectiveness of DAFNE was modelled as a reduction in HbA 1c that affected the risk of developing long‐term diabetes‐related complications. Probabilistic and structural sensitivity analyses were conducted. Results: DAFNE resulted in greater life expectancy and reduced incidence of some diabetes‐related complications compared with no DAFNE.DAFNE was found to generate an average of 0.0294 additional quality‐adjusted life years for an additional cost of £426 per patient, leading to an incremental cost‐effectiveness ratio of £14 400 compared with no DAFNE. There was a 54% probability that DAFNE would be cost‐effective at a willingness‐to‐pay threshold of £20 000 per quality‐adjusted life year. Conclusions: The results of this study suggest that DAFNE is a cost‐effective structured education programme for people with Type 1 diabetes and support its provision by the National Health Service in the UK.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Diabetes Control and Complications (DCCT) Research Group (1995) · Kidney International · doi:10.1038/ki.1995.236 · Cited by 694
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S. (2012) · Diabetes Care · doi:10.2337/dc11-1579 · Cited by 265
Self-citationSpeight, J., Amiel, S. A., Bradley, C., Heller, S., Oliver, L., Roberts, S., Rogers, H., Taylor, C., & Thompson, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.017 · Cited by 160
Self-citationStructured Type 1 Diabetes Education Delivered Within Routine Care
Cooke, D., Bond, R., Lawton, J., Rankin, D., Heller, S., Clark, M., Speight, J., & for the U.K. NIHR DAFNE Study Group (2013) · Diabetes Care · doi:10.2337/dc12-0080 · Cited by 156
Self-citationCederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03342.x · Cited by 90
Cited by
The role of structured education in the management of hypoglycaemia
Iqbal, A., & Heller, S. R. (2018) · Diabetologia · doi:10.1007/s00125-017-4334-z · Cited by 78
Self-citationDiagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance
Amiel, S. A., Pursey, N., Higgins, B., & Dawoud, D. (2015) · BMJ · doi:10.1136/bmj.h4188 · Cited by 45
Economic evaluation of chronic disease self-management for people with diabetes: A systematic review
Teljeur, C., Moran, P. S., Walshe, S., Smith, S. M., Cianci, F., Murphy, L., Harrington, P., & Ryan, M. (2017) · Diabetic Medicine · doi:10.1111/dme.13281 · Cited by 44
Metadata
- Authors
- Kruger, J., Brennan, A., Thokala, P., Basarir, H., Jacques, R., Elliott, J., Heller, S., & Speight, J.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2013-08-19
- Volume
- 30
- Issue
- 10
- Pages
- 1236-1244
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W1985573624
- Cited by
- 42
- References
- 5
- FWCI
- 10.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.